PASSAGE BIO, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.8M | $-7.6M | $-7.7M | $-9.4M | $-15.4M | $-19.3M | $-16.0M | $-16.7M |
| Depreciation & Amortization | — | $129.0K | $200.0K | $200.0K | $201.0K | $800.0K | $800.0K | $806.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $556.0K | — | — | $858.0K | — | — | $1.6M |
| Net Cash from Operating Activities | $-9.2M | $-13.0M | $-4.9M | $-6.3M | $-13.8M | $-7.4M | $-13.1M | $-18.9M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $20.0K | — | — | $39.6M | — | — | $25.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | — | $8.7M |
| Net Change in Cash | — | $-13.0M | — | — | $25.8M | — | — | $15.1M |
| Free Cash Flow | — | — | — | — | — | — | — | — |